OpenURL Connection Search

Select item for more details and to access through your institution.

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
Published in:
Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 12, p. 2545, doi. 10.1007/s00432-017-2504-5
By:
- Beck, Juliane;
- Schwarzer, Andreas;
- Gläser, Dietrich;
- Mügge, Lars-Olof;
- Uhlig, Jens;
- Heyn, Simone;
- Kragl, Brigitte;
- Mohren, Martin;
- Hoffmann, Franz;
- Lange, Thoralf;
- Schliwa, Thomas;
- Zehrfeld, Thomas;
- Becker, Cornelia;
- Kreibich, Ute;
- Winkelmann, Cornelia;
- Edelmann, Thomas;
- Andrea, Marc;
- Bill, Marius;
- Jentzsch, Madlen;
- Schwind, Sebastian
Publication type:
Article
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
Published in:
Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 10, p. 2049, doi. 10.1007/s00432-017-2439-x
By:
- Tessenow, Hannah;
- Holzvogt, Madlen;
- Holzvogt, Bruno;
- Andrea, Marc;
- Heyn, Simone;
- Schliwa, Thomas;
- Schwarz, Maik;
- Zehrfeld, Thomas;
- Becker, Cornelia;
- Pfrepper, Christian;
- Franke, Georg;
- Krahl, Rainer;
- Jentzsch, Madlen;
- Leiblein, Sabine;
- Schwind, Sebastian;
- Bill, Marius;
- Vucinic, Vladan;
- Lange, Thoralf;
- Niederwieser, Dietger;
- Pönisch, Wolfram
Publication type:
Article
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
Published in:
Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 11, p. 2013, doi. 10.1007/s00432-015-1984-4
By:
- Poenisch, Wolfram;
- Plötze, Madlen;
- Holzvogt, Bruno;
- Andrea, Marc;
- Schliwa, Thomas;
- Zehrfeld, Thomas;
- Hammerschmidt, Doreen;
- Schwarz, Maik;
- Edelmann, Thomas;
- Becker, Cornelia;
- Hoffmann, Franz;
- Schwarzer, Andreas;
- Kreibich, Ute;
- Gutsche, Kerstin;
- Reifenrath, Kolja;
- Schwarzbach, Heidrun;
- Heyn, Simone;
- Franke, Georg-Nikolaus;
- Jentzsch, Madlen;
- Leiblein, Sabine
Publication type:
Article
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
Published in:
Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 11, p. 1937, doi. 10.1007/s00432-013-1513-2
By:
- Pönisch, Wolfram;
- Moll, Barbara;
- Bourgeois, Malvina;
- Andrea, Marc;
- Schliwa, Thomas;
- Heyn, Simone;
- Schmalfeld, Marion;
- Edelmann, Thomas;
- Becker, Cornelia;
- Hoffmann, Franz;
- Schwarzer, Andreas;
- Kreibich, Ute;
- Egert, Matthias;
- Stiegler, Runa;
- Krahl, Rainer;
- Remane, Yvonne;
- Bachmann, Anette;
- Lindner, Tom;
- Weidhase, Lorenz;
- Petros, Sirak
Publication type:
Article

Found: 4

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).

Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.